Eli Loots

Eli Loots

Knobbe Martens Olson & Bear LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Lessons From The 1st Biopharma Inter Partes Reviews

Recently, the Patent Trial and Appeal Board issued its first set of final written decisions in three inter partes reviews relating to molecules in the large molecule biopharma space (IPR2013-00534, IPR2013-00535 and...more

7/27/2015 - Biopharmaceutical Biosimilars Inter Partes Review Proceedings Patent Litigation Patent Trial and Appeal Board Patents Pharmaceutical Manufacturers

Garmin International, Inc. v. Cuozzo Speed Technologies, LLC – First IPR Decision Reviewed by Federal Circuit

On February 5, the Federal Circuit issued its first decision on an appeal of a final written decision of an Inter Partes Review (“IPR”). The decision addressed two outstanding questions of interest to IPR proceedings. First,...more

2/14/2015 - Appeals Broadest Reasonable Interpretation Standard Claim Construction Cuozzo Speed Technologies Final Judgment Inter Partes Review Proceedings Patent Infringement Patents Reviewability Determinations

Patent Update for IT and Biotech Companies: New Pieces to the Patent Puzzle

In This Presentation: - PATENT ELIGIBLE SUBJECT MATTER: LIFE IN SOFTWARE/IT AFTER ALICE CORPORATION V. CLS BANK (AND OTHER RECENT 101 DECISIONS) - A Brief History with respect to Software and Biz...more

11/21/2014 - Biotechnology CLS Bank v Alice Corp Direct Infringement Indefiniteness Induced Infringement Limelight v Akamai Mayo v. Prometheus Myriad-Mayo Nautilus Inc. v. Biosig Instruments Patent-Eligible Subject Matter Patents Section 101 Software USPTO

FDA Publishes "Purple Book" for Biosimilars

FDA Publishes "Purple Book" to Catalog Biologics, Interchangeable and Biosimilar Products - The US Food and Drug Administration (“FDA”) recently published its first “Lists of Licensed Biological Products with Reference...more

9/11/2014 - Biosimilars FDA Pharmaceutical Public Health Service Act

Biosimilars Webinar - July 23, 2013

On Tuesday, July 23, Knobbe Martens hosted a live webinar event covering "Preparing for Biosimilars: Key Points for Participating in the U.S. Regulatory Framework." Partners Eli Loots, Carol Pitzel Cruz, and Sheila Swaroop...more

7/26/2013 - Affordable Care Act America Invents Act Biosimilars BPCIA Ex Partes Reexamination FDA Healthcare Patent Reform Patents

SCOTUS: Human Genes Cannot Be Patented. Is This the End or Beginning of Genetic Research?

For a Legal Perspective on today's much-anticipated U.S. Supreme Court "Myriad" decision that naturally occuring substances are not patentable, we turned to IP attorneys writing on JD Supra...more

6/13/2013 - AMP v Myriad Biotechnology DNA Healthcare Human Genes Legal Perspectives Myriad Patents SCOTUS

6 Results
|
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×